戻る
「早戻しボタン」を押すと検索画面に戻ります。 [閉じる]

コーパス検索結果 (１語後でソート)

通し番号をクリックするとPubMedの該当ページを表示します
1 bunit interactions is vital to understanding clinical pharmacology.
2  by the growing importance of such agents in clinical pharmacology.
3 pulation-based approach to advance geriatric clinical pharmacology.
4 , computational modeling and simulation, and clinical pharmacology.
5                              We describe the clinical pharmacology and drug interaction potential of
6 gnized as an important efflux transporter in clinical pharmacology and is potentially important in re
7 enerations of CXCR4 inhibitors with improved clinical pharmacology and safety profiles.
8 brolizumab across indications, complementing clinical pharmacology and single-arm clinical trial data
9 edical Research Council Fellowship Scheme in Clinical Pharmacology and Therapeutics (funding from UK
10                       North West England MRC Clinical Pharmacology and Therapeutics Clinical Research
11 edical Research Council Fellowship Scheme in Clinical Pharmacology and Therapeutics, which is funded
12 ing the underlying pathophysiology, relevant clinical pharmacology, and anecdotal experience.
13  infectious diseases, haematology, oncology, clinical pharmacology, and methodology to develop up-to-
14 mmunology, infectious diseases, dermatology, clinical pharmacology, and pharmacogenomics discussed th
15         The International Union of Basic and Clinical Pharmacology/British Pharmacological Society (I
16 bers of the International Union of Basic and Clinical Pharmacology Committee on Receptor Nomenclature
17 state of knowledge regarding preclinical and clinical pharmacology for brain tumor chemotherapy and e
18                                              Clinical pharmacology for oligonucleotides is less compl
19 n as "hepatocyte hopping"-a novel concept in clinical pharmacology-for detoxification of targeted can
20 opulation was performed at the Department of Clinical Pharmacology in cooperation with the Center for
21                                              Clinical Pharmacology in Neuroscience Drug Discovery in
22 d to the challenge of carrying out increased Clinical Pharmacology in the Neurosciences.
23 specific tasks involving extracting relevant clinical pharmacology information from regulatory drug l
24 oped by the International Union of Basic and Clinical Pharmacology (IUPHAR) and the British Pharmacol
25         The International Union of Basic and Clinical Pharmacology (IUPHAR) database, IUPHAR-DB is an
26 y and Nutrition and the Ethics Committee for Clinical Pharmacology (KFEB) of Hungary and from the Min
27 ith the highest rate of appropriate use were Clinical Pharmacology/Micromedex support (6 of 7 antimic
28 ed by electronic drug information resources (Clinical Pharmacology/Micromedex), or study site princip
29                           The current use of clinical pharmacology, molecular biology, and clinical r
30                The current paper reviews the clinical pharmacology of 5-MeO-DMT and DMT and their pot
31 urrent knowledge of obesity's effects on the clinical pharmacology of anesthetic drugs.
32 e the toxicity profile, and characterize the clinical pharmacology of irinotecan and its metabolites.
33                          Here I overview the clinical pharmacology of leukotriene antagonists and app
34 or more than three decades, 'experts' in the clinical pharmacology of neuromuscular blocking agents h
35          Herein, we review the molecular and clinical pharmacology of this venerable class of drugs,
36 experts in medical and gynecologic oncology, clinical pharmacology, pharmacokinetics and pharmacogene
37  challenges and provide guidance on neonatal clinical pharmacology research on antiretroviral agents
38 his viewpoint, we provide considerations for clinical pharmacology research to provide safe and effec
39 ebo-controlled, phase 1 study at the PAREXEL Clinical Pharmacology Research Unit (Harrow, Middlesex,
40                                     Notably, clinical pharmacology studies play a central role in int
41                                              Clinical pharmacology studies that describe the pharmaco
42 rrection formulas can be proposed for future clinical pharmacology studies that show drug-induced hea
43           Serial blood and urine samples for clinical pharmacology studies were obtained in a subset
44                               We conducted a clinical pharmacology study among patients treated for T
45 Drugs and Biologics Compendium, DRUGDEX, and Clinical Pharmacology to the list of compendia.
46 was conducted with healthy participants in a clinical pharmacology unit (Spaulding Clinical Research,
47 bo-controlled, crossover clinical trial at a clinical pharmacology unit (West Bend, Wisconsin) conduc
48 PARTICIPANTS: Randomized clinical trial at a clinical pharmacology unit (West Bend, Wisconsin) was co
49  double-blind, crossover clinical trial at a clinical pharmacology unit (West Bend, Wisconsin) with 2
50                 In this study conducted in a clinical pharmacology unit and examining sunscreen appli
51 omized clinical trial conducted at a phase 1 clinical pharmacology unit in the United States and enro
52 tudy of 145 healthy adults in 2 US inpatient clinical pharmacology units.